Genes encoding transcription factors are frequently altered by chromosomal translocations in acute lymphoblastic leukemia (ALL), suggesting that aberrant transcriptional regulation plays a prominent role in leukemogenesis. E2A-hepatic leukemia factor (HLF), a chimeric transcription factor created by the t(17;19), consists of the amino terminal portion of E2A proteins, including two experimentally defined transcriptional activation domains (TADs), fused t o the HLF DNA binding and protein dimerization basic leucine zipper (bZIP) domain. To understand the mechanisms by which EPA-HLF induces leukemia and the crucial functions contributed by each constituent of the chimera, it is essential t o define the normal transcriptional regulatory properties of HLF and related bZlP proteins. To address these questions, we cloned the human homologue of TEF/VBP, a bZlP protein closely related t o HLF. Using a binding site selection assay, we found that TEF bound preferentially t o the consensus sequence 5'-GlTACGTAAT-3', which is identical t o the pre-
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BERRANT TRANSCRIPTIONAL regulation is im-
A portant in the pathogenesis of human cancer. In the leukemias, genes encoding transcription factors are frequently affected by chromosomal translocations.' One category of translocations leads to creation of fusion genes that encode chimeric proteins with novel structural and functional features not possessed by the constituent wild type proteins. In B-precursor acute lymphoblastic leukemia (ALL), the E2A gene, which encodes the basic helix loop helix (bHLH) transcription factors E12 and E47, is interrupted by two different translocations that create distinct chimeric transcription factors (Fig 1) .2-6 As a result of the t(1;19)(q23;p13), the E2A carboxy terminus, including the bHLH DNA binding and protein dimerization domains, is replaced with a region of PBXl containing a heterologous DNA binding Following the t( 17; 19)(q21-22;~13), the same general portion of E2A proteins is fused to the basic leucine zipper (bZIP) DNA binding and protein dimerization domains of hepatic leukemia factor (HLF).5. 6 The portion of E2A proteins included in these chimeras includes two separate experimentally defined transcriptional activation domains (TADs).'.~ Based on these structural features, it has been predicted that E2A-PBX1 and E2A-HLF contribute to leukemogenesis by aberrantly activating transcription of target genes that contain binding sites recognized by PBXl or HLF (reviewed in Hunger"). Due to the substantial overlap in sites bound by related transcription factors, it is not certain whether the important E2A-PBX1 and E2A-HLF target genes are normally regulated by wild type PBXl and HLF, or by other proteins with similar DNA binding properties. As E2A-PBX1 and E2A-HLF bind to completely different DNA sequences in vitro,"-15 it is assumed that the target genes affected by these two protein chimeras are distinct and nonoverlapping. However, because bona fide E2A-PBXl and E2A-HLF target genes have not yet been identified, this assumption has not been confirmed experimentally.
Interestingly, wild type PBXl and HLF are not present in normal lymphoid cells, as their genes are transcriptionally viously determined HLF recognition site. TEF and HLF activated transcription of consensus site-containing reporter genes in several different cell types with similar potencies. Using GAL4 chimeric proteins, a TAD was mapped t o a discrete -40 amino acid region of TEF and HLF within which they share 72% amino acid identity and 85% similarity. The TEF/HLF activation domain (THAD) has a predicted helical secondary structure, but shares no sequence homology with previously reported TADs. The THAD contained most, if not all, of the transcriptional activation properties present in both TEF and HLF and its deletion completely abrogated transcriptional activity of TEF and HLF in both mammalian cells and yeast. Thus, TEF and HLF share indistinguishable DNA-binding and transcriptional regulatory properties, whose alteration in leukemia may be pathogenetically important. 0 1996 by The American Society of Hematology.
silent in this lineage.3-6 Thus, it is important to consider whether fusion to E2A is essential for leukemogenesis, or if ectopic expression of wild type PBXl or HLF might also be transforming. This question has been addressed experimentally for PBXl (which does not function as a transcriptional activator by itself"-13), and it is clear that fusion to E2A is absolutely required for transformation.16 Surprisingly, the PBXl homeodomain, which mediates site-specific DNAbinding, is not required for transformation in experimental systems.L6 This does not necessarily mean that DNA-binding is a dispensable function, as E2A-PBX1 and PBX proteins appear to function in a heteromeric complex with other HOX proteins.I7 Thus, the homeodomain-deleted E2A-PBX 1 may be tethered to DNA targets via retained protein-protein interactions. E2A-HLF has also been shown to be capable of transforming NIH 3T3 fibroblasts, but the potential oncogenic properties of wild type HLF have not been tested."
For personal use only. Transformation requires the integrity of the HLF leucine zipper (that mediates protein dimerization, an essential prerequisite for DNA binding) and both E2A TADs, suggesting that the ability to activate transcription of target genes is necessary for E2A-HLF-induced transformation.'* We have shown previously that wild type HLF activates transcription of reporter genes containing concatamerized HLF binding sites in several different cells types, including human ALL cell lines phenotypically similar to those in which the t( 17; 19) OCCUTS.'~ If activating transcription of target genes that contain binding sites recognized by HLF is the sole requirement for transformation, wild type HLF, and other proteins with similar transcriptional regulatory properties, might also be able to function as oncogenic transcription factors.
HLF is a member of a small subfamily of bZIP proteins that also includes D binding protein (DBP), and thyrotroph embryonic factor (TJZF) and its chicken homologue vitellogenin binding protein (VBP).'9-2' These three proteins share substantial homology within the bZIP domains and within an adjacent domain rich in proline and acidic amino acids (the PAR). The three PAR proteins bind to an overlapping set of DNA target sequences as homodimers, or when heterodimerized with other PAR, but not other non-PAR, bZIP proteins.5.14.15.20-23 We and others have identified an HLF consensus DNA binding site, 5'-GTTACGTAAT-3'.'415 This consensus site shares significant homology with the promoter-derived sequences originally used to clone DBP and TEFNBP.I9"' As is the case for HLF, the other PAR proteins can also activate transcription of reporter genes in transient transfection assays. DBP functions as a transcriptional activator in cells of hepatic origin, but not in other cell TEF activates transcription in monkey kidney-derived CV-1 cells, and VBP has been shown to be a transactivator in chicken fibroblast-and hepatoma-derived cell line^.*^.*^ To better understand the biochemical mechanisms by which E2A-HLF induces leukemia and the crucial functions contributed by each constituent of the chimera, we investigated the normal transcriptional regulatory properties of wild type HLF and TEF. Our studies show that these two proteins have virtually indistinguishable in vitro DNA-binding and transcriptional regulatory properties. Furthermore, the transcriptional activation potential of both proteins is contained within a highly conserved domain that we term the THAD (TEFMLF --Activation Domain). One fundamental consequence of the t(17;19)% replacement of the HLF THAD with heterologous E2A TADs, raising the possibility that alterations in protein-protein interactions between transcriptional activators and components of the general transcription machinery may contribute to leukemogenesis.
MATERIALS AND METHODS
A cDNA library derived from the human B-precursor ALL cell line HB 11 192h was screened at reduced stringency (final wash 2 x SSC [I x SSC is 0.15 molL NaCl with 0.015 molL sodium citrate] and 0.1% sodium dodecyl sulfate at 52°C) with a polymerase chain reaction (PCR)-generated cDNA probe, which consisted of the entire open reading frame (OW) of HLF. Four independent plaques were purified to homogeneity, and the phage inserts were characterized by restriction enzyme mapping, then subcloned into the Bluescript plasmid vector (Stratagene, La Jolla, CA) for nucleotide sequence analysis using commercially prepared reagents (USB, Cleveland, OH).
Electrophoretic mobility ship assays (EMSA) and consensus binding site selection. EMSA were performed as described previously with proteins translated in vitro (IVT) from expression plasmids using a coupled reticulocyte lysate system (Promega, Madison, WI).5.'4 The oligonucleotides used in EMSA contained the binding site of interest in an identical backbone derived from the VBP site in the chicken VTG I1 promoter.*' Binding sites used included the HLF/TEF consensus 5'-GTTACGTAAT-3''4.'5 (and this report), a TEF binding site (5'-GTTACGCAAG-3') present in the rat growth hormone (GH) promoter:' a VBP binding site (5'-mATGTAAA-3') present in the chicken VTG I1 promoter:' and a consensus binding site (5'-CTGACGTCAG-3') for ATF proteins." Single-stranded oligonucleotides were annealed, labeled by Klenow fill-in, and unincorporated nucleotides were removed by passing the resultant double-stranded oligonucleotide through a Nuctrap column (Stratagene). To determine the consensus TEF DNA binding site, a modified version of the selective amplification and binding (SAAB) procedure*' was performed exactly as described previou~ly.'~ After 5 rounds of SAAB, the amplified product was cloned into a plasmid vector. The nucleotide sequences of independent clones were determined as previously described and visually aligned. Only sequences (n = 19) derived entirely from the internal degenerate positions were used to determine the consensus binding site.
For IVT, the entire ORF and -2.5 kb of 3' untranslated sequence of the longest TEF cDNA was cloned into the pSP65 vector (Promega) to make pSP65-TEF. For transient transfections, the same portion of the TEF cDNA was cloned into the pCMV expression vector; pCMV-HLF has been described previou~ly.'~ To define the regions of TEF and HLF capable of activating transcription, various portions of the TEF and HLF cDNAs were fused in-frame to a cDNA encoding amino acids 1-147 of GAL4 in Cloning of human TEF cDNAs.
Plasmid constructions.
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From the plasmid ~S G 4 2 4 ;~ either by use of convenient restriction sites or by PCR amplification. The resultant plasmids express fusion proteins that consist of amino acids 1-147 of GAL4 (which allow binding to cognate GAL4 DNA binding sites and also contain a nuclear localization signal), from 3-15 amino acids encoded by the plasmid polylinker and varying portions of TEF or HLF. The nomenclature of constructs indicates the portion of TEF or HLF fused to GAL4 ; for example, GU-TEF(-12--+303) contains the entire TEF open reading frame including 12 residues amino terminal to the first methionine codon. Based on the results of transcriptional assays with the GAL4 chimeras, TEF and HLF expression vectors that lacked the putative TAD were constructed by using PCR to add restriction sites for deletion and cloning. To detect both full-length and deleted TEF and HLF proteins in transfected cells, pCMV-TEFnAG, pCMV-TEFA74-1 14nAG, pCMV-HLFPLAG, and pCMV-HLFA59-103nAG were constructed; each contains the heterologous FLAG epitope (amino acid sequence DYKDDDDK) added to the carboxy terminus of the protein. For experiments performed in yeast, the plasmid pBTM116 (constructed originally by Paul Bartel and Stan Fields, Department of Microbiology, State University of New York, Stony Brook) was used.30 This plasmid carries the TRPl gene that allows selection in media lacking tryptophan and encodes full-length lexA followed by several unique restriction endonuclease recognition sites. Wild type and deleted versions of TEF and HLF were cloned in-frame to the lexA sequence of pBTM116 to generate lexA-TEF, lexA-TEFA74-114, lexA-HLF, and lexA-HLFA59-103. The integrity of all constructions was verified by restriction enzyme mapping and the nucleotide sequence of portions generated by PCR was determined to ensure that no mutations had been introduced.
Transient transfections and transcriptional activation assays. Various reporter constructs were used that contain concatamerized DNA recognition elements adjacent to one of several promoters that drive expression of a chloramphenicol acetyl transferase (CAT) gene. The reporters referred to as (HLFI~XF)~-TK-CAT and (HLF/ TEF)4-AP-CAT have been described previously as HLF4-TK-CAT and HLF4-AP-CAT; these contain four tandem repeats of the consensus binding site 5'-GTTACGTAAT-3' (contained within the VBP VTG I1 oligonucleotide backbone) adjacent to either the herpes simplex virus (HSV) thymidine kinase (TK) or liverhonekidney alkaline phosphatase (AP) pr0m0ter.I~ For experiments with GAL4 chimeras, the reporters GAL4-Elb-CAT3' and GAL4-TK-CAT" were used. These contain two tandem copies of the GAL4 recognition element adjacent to either the adenovirus Elb or HSV TK promoter. A reference plasmid expressing either the luciferase (pSVTK-Luc) or lacZ (pCMV-PGal) gene was used to control for transfection efficiency.
Adherent cell lines CV-1 and C o s 7 were transfected by the calcium phosphate method as described previou~ly.'~ Briefly, 2 to 4 x lo5 cells were plated onto 60 mm tissue culture dishes approximately 24 hours before transfection, and new media was applied to the dish 2 to 8 hours before transfection. Each plate was transfected with a total of 15 pg of DNA, which included 2.5 pg each of the CAT reporter, expression vector, and transfection control plasmid. Transfections were performed in duplicate, extraneous plasmid DNA was and incubated on ice for 15 to 30 minutes. H a l f of this solution was then added dropwise to each of two plates, immediately followed by 10 to 30 pL of 10 mmoVL chloroquine. Sixteen hours following transfection the medium was removed, the plates were washed twice with phosphate-buffered saline (PBS), and new medium was applied. The cells were procured 40 to 48 hours after transfection and lysed by the freeze-thaw method. The B-precursor ALL cell line REH was transfected by electroporation using diethyl aminoethyl (DEAE)-dextran exactly as described previou~ly.'~ CAT and luciferase assays were performed on cell lysates as previously de~cribed.'~ Acetylation of chloramphenicol was assayed by thin layer chromatography separation of the reaction products and quantified on a PhosphorImager (Molecular Dynamics, Santa Clara, CA). Light emission from luciferase reactions was quantified with a luminometer (Analytical Luminescence Laboratories, San Diego, CA). @-galactosidase activity was determined by measuring the optical density at 420 nm as described.'' CAT activities were normalized based on the relative transfection efficiencies as determined by the luciferase or P-galactosidase assays. Each experiment was performed in duplicate on at least three separate occasions. Values are expressed as the arithmetic mean 2 the standard deviation.
For Western (immunoblot) analyses, cells were transfected in 60 mm plates exactly as previously described and harvested 48 to 72 hours following transfection. The cell pellet from each plate was lysed in protein loading buffer, boiled for 5 minutes and separated by SDS-polyacrylamide gel electroph~resis.'~ Following electrophoresis, proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA) by semidry electrophoretic transfer. Proteins were detected using commercially obtained monoclonal antibodies as recommended by the supplier, and visualized by chemiluminescence (Amersham, Buckinghamshire, UK). The M2 anti-FLAG antibody (IBI, New Haven, CT) was used with the FLAGtagged constructs and the GAL4 chimeras were detected with a mouse monoclonal antibody raised against GAL4 amino acids 1-147 (Santa Cruz Biotechnology, Santa CNZ, CA).
To determine the subcellular localization of transfected proteins, 4 X lo4 NIH 3T3 cells were plated into each well of 2-well chamber slides and allowed to grow for approximately 18 hours. Cells were transfected by the calcium phosphate precipitation method with 5 pg of each plasmid construct. Approximately 20 hours following transfection, the cells were washed with PBS and fresh media added. The following day the cells were washed with PBS, fixed with 2% paraformaldehyde in PBS for 15 minutes, rinsed with PBS, permeabilized with 0.5% Triton X-100 in PBS for 30 minutes and blocked with a solution of 2% bovine serum albumin (BSA) in PBS (BSAPBS) for 5 minutes. The anti-FLAG antibody was added at a dilution of 1:200 in PBSBSA and allowed to incubate at room temperature for 2 hours. Following incubation, the slides were washed for 5 minutes in PBS and then incubated with a biotinylated goat antimouse antibody (1:500 in PBS/BSA for 1 hour). The washing step was repeated and the slides were incubated with streptavidin-horseradish peroxidase (1:500 in PBSBSA for 1 hour). The slides were washed again, developed with 3-amino-9-ethyl-carba~o l e ?~ counterstained with aqueous hematoxylin and mounted with Crystal Mount (Biomeda Corp, Foster City, CA).
Yeast transformations were performed in the Sacchromyces cerevisiae strain ~4 0 , " a generous gift from Stan Hollenberg (Vollum Institute, Oregon Health Sciences University, Portland), using lithium acetate and polyethylene glycol basically as described by Gietz et al?6 This strain contains two reporter genes, lacZ and HIS3, whose expression is driven by minimal GAL1 and HIS3 promoters, respectively, fused to multimenzed lexA binding sites. Yeast transformed with the l e dencoding plasmid pBTM116 cannot grow well on media lacking histidine or produce significant amounts of &galactosidase. If a TAD capable of functioning in yeast is fused to lexA, the lexA chimera can then grow on histidine-negative media and produce @-galactosidase. @-galactosidase activity was assayed on nitrocellulose filters after transfer of yeast colonies from plates. The filters were quickly frozen by immersion in liquid nitrogen and, after thawing, placed in a petri dish containing a filter paper soaked in 1.5 mL of Z buffer (60 mmol/L Na,HPO,, 40 mmoVL NaH2P0,, 10 mmol/L KCl, 1 mmoV L MgS04, pH 7.0) containing 15 pL of X-gal (5-bromo-4-chloro3indolyl-P-D-galactosidase; GIBCO-BRL, Gaithersburg, MD). The plates were covered, incubated in a humidified chamber at 30°C for several hours to ovemight and inspected visually for evidence of blue color change.
RESULTS

Cloning and expression pattern of human TEF cDNAs.
To directly compare the DNA\binding and transcriptional regulatory properties of TEF to those of HLF, we set out to clone the cDNA encoding the human homologue of TEF/ VBP. A cDNA library derived from the ALL cell line HB 11 1926 was screened at reduced stringency with an HLF cDNA probe, and four independent clones were isolated that contained cDNA inserts ranging in size from approximately 2.5 to 4.3 kb. The longest cDNA contained an ORF of 945 nucleotides starting at its 5' end and included approximately 3.3 kb of 3' untranslated sequence followed by a poly-A tail (Fig 2A) . The other three cDNAs contained shorter versions of the same sequence; no evidence of alternative splicing within the coding region was observed. An ATG codon beginning at nucleotide 37 is in a favorable context for initiation of tran~lation.~' Data base searches indicted that the 303 amino acid protein encoded by these cDNAs (GenBank accession number U44059) was the human homologue of TEFNBP and will be referred to herein as TEF.","
Chicken VBP (both the a and ,C? isoforms") diverges significantly from human TEF at the amino terminus (Fig 2B) , but the remainder of the proteins share 88% amino acid identity. The rat TEF cDNA originally reported by Drolet et alZ0 encodes a protein that is 99% identical to human TEF, but includes 42 fewer amino-terminal residues. Similarly, Khatib et a13* recently reported isolation of a human TEF cDNA that begins at nucleotide 113 of that described herein, conceptual translation of this cDNA also predicted a protein lacking the initial 42 amino acids shown in Fig 1B. These two human TEF cDNAs are otherwise identical except for two minor differences: the cDNA reported by Khatib et a1 contains a G, rather than an A, at nucleotide 196 (predicting GId4 rather than L Y S~~) , and contains a T, rather than a C, at nucleotide 498. The difference in the predicted amino terminal sequence of TEF results from conceptual translation beginning at an ATG codon corresponding to the second one present in the human TEF cDNA we isolated. Several observations suggest that the rat TEF cDNA and the human TEF cDNA described by Khatib38 are not full length. First, 3 1 nucleotides are present in the rat cDNA 5' of the first ATG codon; 28 of these are identical to those in the corresponding position of human TEF, and they specify the same 10 amino acids. In addition, when these cDNAs are in vitro translated side-by-side, the human TEF cDNA we isolated encodes a protein 5 to 7 kD larger than the rat cDNA, consistent with translation beginning at the first ATG codon (data not shown). We cannot rule out the possibility that human TEF includes additional amino terminal residues, as the longest clone isolated does not contain a stop codon 5' of the first ATG.
By Northern analysis the TEF transcript is a single band measuring approximately 4.5 kb (data not shown). Consistent with previous observation^,^^ TEF mRNA was found to be expressed at modest levels in each of several different human ALL cell lines tested and in the HepG2 hepatocellular carcinoma cell line (data not shown). This pattern of expression is distinct from that of HLF, which is also expressed in HepG2, but is transcriptionally silent in all hematolymphoid cell lines t e~t e d .~.~ TEF and HLF bind preferentially to the same core consensus DNA sequence in vitro. To identify the TEF consensus DNA binding site, a modified version of the SAAB procedure'' was performed using IVT TEF and a radiolabeled double-stranded oligonucleotide that contained 20 central degenerate positions. Following five rounds of selection and amplification, an intense shifted complex was visible with TEF protein, but not with a negative control IVT programmed with vector alone. The DNA in this complex was amplified again and cloned into a plasmid vector. The nucleotide sequence of individual clones was determined and aligned visually to derive the TEF consensus binding site: S'-GlTACGTAAT-3' (Fig 3A) . For each position, the consensus nucleotide was present in at least two thirds of the individual clones, and several were present in 90% to 100%. This consensus binding site is identical to that we previously obtained for HLF, and the frequency of individual nucleotides at each position is quite ~imi1ar.l~ A parallel selection using C E B P a protein"' identified a different consensus sequence (data not shown) indicating that the binding site selection procedure employed is not biased in favor of this sequence. In addition, the identical consensus recognition sequence was identified for HLF by Inaba et all5 and for VBP by Haas et al" using different binding site selection procedures. Taken together, these results indicate that HLF and TEF bind preferentially to the same core DNA sequence in vitro.
To confirm that the identified consensus sequence was a high affinity TEF binding site, EMSA was performed with and without 100-fold molar excess of various unlabeled competitor oligonucleotides (Fig 3B) . In the absence of specific competitor, TEF bound to the consensus binding site; this binding was completely eliminated by preincubation with excess unlabeled consensus site or with a closely related site present in the rat GH promoter that both TEF and HLF are known to bind The more divergent VTG 11 site that was used to clone VBP was a less efficient competitor. The consensus binding site for ATF proteins, which comprise a distinct bZIP subfamily, competed minimally for binding. In separate experiments in which TEF and HLF binding to a panel of these and other sites was compared, both proteins displayed an indistinguishable pattern of binding site preferences (data not shown). Thus, these two proteins that possess significant structural homology within the basic and adjacent regions known to mediate DNA binding, display very similar, if not identical, in vitro DNA binding properties.
TEF fiinctions as a transcriptional activator with a potency similar to HLF. To assess whether TEF transactivation was cell type-specific and to compare the relative transcriptional potencies of TEF and HLF, transient transfections were performed with CAT reporter genes under control of a minimal promoter with adjacent concatamers of the HLF/ TEF consensus binding site. In the human B-precursor ALL cell line REH, both TEF and HLF activated transcription of the (HLF/TEF),-TK-CAT reporter gene to levels approximately fivefold higher than that seen with the pCMV expression vector alone (Fig 4) . Similar results were observed when transfections were performed in CV-I , cos-7, and NIH-3T3 cells (data not shown; see also Fig 7) .
Ident$cation of a highlv conserved transcriptional activation domain in TEF and HLF. Previous studies have shown that the transcriptional activation properties are contained predominantly within the amino terminal halves of rat TEF and HLF.I4.'" Comparison of the amino acid sequences of these portions of the proteins shows that there is an -40 amino acid region where TEF and HLF share 72% identity and 85% similarity (Fig 5A) . This region is also present in DBP, the third member of the PAR subfamily of bZIP proteins, but the homology between TEF and HLF is higher than that between either protein and DBP. Outside of this region, the amino terminal halves of the PAR proteins con- tain only short stretches of homology and are generally dissimilar. Given the similar transcriptional properties of TEF and HLF, we postulated that this region of homology might be a TAD. This hypothesis was first tested by fusing various portions of the human TEF cDNA in-frame to GAL4 amino acids 1 -147 in the plasmid pSG424" and assaying the ability of GALCTEF chimeric proteins to activate transcription of CAT reporter genes containing GAL4 binding sites.
A GAU-TEF( -12--+303) chimeric protein (construct I ) that contained the entirety of the longest human TEF cDNA (including 12 residues specified by codons 5' of the first ATG) activated transcription approximately 10-fold over background levels observed with GAL4 amino acids 1-147 alone (Fig 6A) . Similar results were observed using GAL4-CAT reporters that contained either an adenovirus E l b or HSV TK promoter. All constructs that contained TEF amino acids 72-1 16 (the region of HLF homology) activated transcription as much, or more, than the full length GALCTEF chimera. Constructs that lacked this portion of TEF were at or near background levels of CAT activity. Most instructively, when this domain was discreetly deleted (constructs 9 and lo), CAT activity was reduced to background levels. Some differences were observed in the magnitude of activation of the two reporter constructs; these are primarily a consequence of higher baseline CAT activity observed with To ensure that the observed differences in transcriptional properties were not due to differences in the level of protein expressed, identical experiments were performed in cos-7 cells, and the CAT activity of cell lysates was compared with the level of protein expressed as determined by immunoblot analysis with a monoclonal antibody raised against GAL4 amino acids 1-147 (Fig 6B and C) . Although modest differences were observed in the levels of protein expressed, these differences did not correlate with transcriptional activity. Similar high levels of expression were seen for GAL4-TEF chimeras 1, 2, 8, 9, and 10; the first two were transcnption-GALCTK-CAT. ally active, while the last three were completely inactive (data not shown). Consistently lower levels of expression were seen for chimeras 3, 4, 6, and 7, yet the transcriptional potency of the first two differed markedly from the latter two (Fig 6B and C) . We conclude from these experiments that, in the context of fusion to the heterologous GAL4 DNA binding domain, TEF amino acids 72-114 are absolutely required for transcriptional activation and contain most, if not all, of the transcriptional activation potential present in the full-length protein.
To determine whether the homologous region of HLF also functioned as a TAD, a more limited series of GAL4-HLF constructs was generated, and the ability of GAL4-HLF fusion proteins to activate transcription of the GAL4-E1 b-CAT reporter was assessed following transient transfection into CV-I cells (Fig 6D) . GALCHLF activated transcription approximately 25-fold over background levels observed with GAL4 1-147 alone. Deletion analysis showed that HLF amino acids 60-102, the region of TEF homology, functioned as a discrete TAD when fused to GAL4 1-147 and, similar to TEF amino acids 72-116, contained most, if not all. of the transcriptional activation potential present in the fulllength protein. Experiments performed in cos-7 cells confirmed these observations and shown that similar amounts of each of the GAL4-HLF chimeric proteins were produced (data not shown).
Deletion In the lower portion, the percent amino acid identity between TEF and HLF or DBP is indicated for each domain. The cross-hatched region is the minimal TEF transcriptional activation domain identified in these studies. PAR, proline, and acidic amino acid rich region; BRE, basic region extension; bZIP, basic leucine zipper. (B) The amino acid sequence (single letter abbreviation) of the regions of TEF and HLF that comprise the THAD and are deleted in pC?~lV-TEFA74-114~~ and pCMV-HLFA59-103FUG. The corresponding region of human DBF' is also shown; gaps, indicated by dashes, are introduced t o maintain alignment. Amino acid identity is denoted by dashes and similarity by pluses between the residues. Within this region TEF shares 72% amino acid identity and 85% similarity with HLF, 51% identity and 78% similarity with DBP, and HLF shares 56% identity and 77% similarity with DBP. A portion of the THAD predicted t o assume an a-helical configuration is indicated. No binding site-independent transactivation was observed. When activators were cotransfected with CAT reporter constructs lacking GAL4 binding sites, only background levels of CAT activity (indistinguishable from those observed when pSG424 was cotransfected with GAL4-TK-CAT or GAL4-E1 b-CAT1 were observed. (E) Representative results of CAT assays assessing the ability of select GAL4-TEF chimeric proteins t o activate transcription of the GAL& Elb-CAT reporter following transient transfection into cos-7 cells. Transfections were performed in duplicate, and one plate was harvested for CAT assays and the other for immunoblot analysis. In these experiments, CAT assays were allowed t o go t o completion t o highlight the profound differences in transcriptional activation. The location of acetylated and nonacetylated products is indicated at the right. The constructs are numbered as in (A). IC) lmmunoblot analysis of transfected cos-7 lysates using a monoclonal antibody directed against GAL4 amino acids 1-147. The migration of molecular weight markers (in kilodaltons) is indicated at the left of the blot. The constructs are numbered as in (A). ID) The ability of GAL4-HLF chimeric proteins t o activate transcription of GAL4-Elb-CAT was assessed following transient transfection into CV-1 cells. Results are expressed as the fold activation of CAT activity as compared with cotransfection of the reporter with pSG424 and are the arithmetic mean of duplicate determinations performed in three independent experiments. Standard deviations are displayed as error bars.
with and without this conserved domain (the amino acid sequence of portions of TEF and HLF deleted in these constructs is shown in Fig 5B) . The heterologous FLAG epitope was added to the carboxy terminus of each construct so that protein expression could be directly compared. Transcriptional activation of an (HLF/TEF),-AP-CAT reporter was increased approximately fivefold over background levels seen with the pCMV vector alone by both pCMV-TEFnAG and pCMV-HLFFLAG (Fig 7A) . The transcriptional potency of these constructs was indistinguishable from constructs lacking the FLAG epitope (data not shown). In contrast, pCMV-TEFA74-1 14""G and pCMV-HLFA59-1 03nAG were completely incapable of activating transcription of the reporter gene. In fact, these constructs acted as dominant negative inhibitors of transcriptional activation by endogenous proteins as they significantly reduced the binding site-dependent baseline activation seen with the (HLF/ TEF),-AP-CAT reporter. When the full-length and deleted constructs are directly compared, pCMV-HLFF'-"" is 27.6 2 7.7-fold more active than pCMV-HLFA59-103""' and pCMV-TEF'""" is 13.0 t 4.6-fold more active than pCMV-TEFA74-1 14","G. Similar results were observed when identical experiments were performed with the (HLF/TEF),-TK-CAT reporter (data not shown). Western (immunoblot) analysis with an anti-FLAG monoclonal antibody showed that equivalent amounts of each of the protein constructs are present in transfected cos-7 cells indicating that protein stability was not affected by the deletions (Fig 7B and C) .
To ensure that the failure to activate transcription was not because of an alteration in protein subcellular localization, NIH-3T3 cells were transiently transfected and immunocytochemistry was performed with an anti-FLAG monoclonal antibody. Each of the full-length and deleted proteins was found to be located almost exclusively in the nucleus (Fig   8) .
In summary these studies show that TEF and HLF each contain a highly homologous -40 aa TAD that will be referred to subsequently as the THAD (Fig 5B) . Data base searches indicate that the THAD is unique to the PAR subfamily of bZIP proteins. Structural analysis using the ChouFasman algorithm predicts that a central 16 amino acid portion of this domain assumes an a-helical configuration. There are no other obvious structural features present in the THAD; of 40 amino acids TEF has 5 prolines, 4 serines, and 1 threonine, while HLF possesses 5, 3 and 3 of the respective amino acids.
It is currently believed that TADs effect their function by interacting, directly or indirectly, with protein components of the general transcription machinery.'" As many of these factors are highly conserved throughout evolution, we investigated whether HLF and TEF could activate transcription in yeast. Fulllength and THAD-deleted HLF and TEF cDNAs were fused in frame to a cDNA encoding lexA in the plasmid pBTM 1 16, used to transform the yeast strain L40 and tested for their ability to activate transcription in vivo of HIS3 and lacZ reporter genes with adjacent lexA binding sites. Yeast transformed with IexA-HLF and IexA-TEF grew avidly on histidine-negative plates, whereas yeast transformed with IexA-
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For personal use only. on August 30, 2017. by guest www.bloodjournal.org From HLFAS9-IO3 and Iex A-TEFA74-I 14 were incapable of growth ( Table l ) . Similarly. yeast transformed with IexA-HLF and IexA-TEF were strongly positive in the P-galactosidase filter assay, while those transformed with IexA-HLFAS9-103 and IexA-TEFA74-I 14 did not exhibit any color change, even after overnight incubation. These data indicate that the THAD functions as a TAD in yeast, as well as in mammalian cells. suggesting that it interacts with HUNGER ET AL proteins that are conserved throughout millions of years of evolution.
DISCUSSION
In these studies, we have compared the DNA-binding and transcriptional regulatory properties of human TEF and HLF and found them to be strikingly similar. Both bound preferentially to the same core consensus DNA sequence in vitro and no differences were detected in binding to a panel of related sites. DBP, the third known PAR-bZIP protein, binds to similar target sites, but its optimal recognition element has not been defined.s.'".'J.J'~53 These findings are consistent with the fact that the three PAR proteins share extensive homology within the basic and adjoining regions known to mediate DNA binding. In transient transfection assays, TEF and HLF activated transcription of consensus site-containing CAT reporter genes in each of several cell types (REH, CV-I . Cos-7. NTH 3T3) tested and their potencies were quite similar to one another within each cell type. These observations suggested that TEF and HLF might contain structurally Deletion of the THAD does not affect nuclear localization of TEF and HLF. NIH 3T3 cells were transiently transfected with the indicated constructs containing the FLAG epitope tag and immunocytochemistry was performed using a monoclonal antibody directed against the FLAG epitope. A secondary biotinylated goat antimouse IgG antibody was used and visualized with streptavidin-horseradish peroxidase. Slides were photographed in color and printed as black and white negative images. Cells transfected with each of the four constructs contain FLAG-tagged protein that is almost exclusively localized to the nucleus. L4030) containing the above constructs were tested for their ability to grow on plates lacking histidine (his-) and to produce b-galactosidase. Growth on his-plates required activation of the HIS3gene whose expression was driven by a minimal HIS3 promoter fused to multimerized lexA binding sites.
Growth was scored as: -no growth; +/-slow growth that was inhibited by 3-aminotriazole (3-AT); ++ abundant growth unaffected by 3-AT. &galactosidase activity required activation of the lacZ gene whose expression was driven by a minimal GAL7 promoter fused to multimerized lexA binding sites. Activity was determined using a colorimetric filter blot assay (-no color change after overnight incubation; + weak blue color after overnight incubation; +++ strong blue color change evident within 1 to 2 hours). similar TADs. Previous studies had shown that the transactivation properties of both TEF and HLF were not contained within the highly conserved PAR or bZIP domains, but rather mapped to the amino terminal halves of each pr~tein.'~.'' This line of reasoning focused our attention on a region of -40 amino acids within which TEF and HLF share 72% amino acid identity and 85% similarity. Using both GAL4 chimeras and native TEF and HLF proteins, we found that this domain, termed the THAD, contains most, if not all, of the transcriptional potency and is absolutely required for transcriptional activation by TEF and HLF. Because the transcriptional competency of subfragments of the THAD was not determined, it is possible that the actual TAD might be somewhat smaller than that defined in this report.
Based on these observations, one would anticipate that TEF and HLF would be capable of activating transcription of an overlapping set of target genes in vivo. One manner by which the function of these proteins might vary is via differences in their expression profiles. Indeed, HLF displays a very restricted pattern of mRNA expression in adult human tissues, while TEFNBP mRNA is expressed relatively ubiquitously in rat and ~h i c k e n .~~~~'~~' ' Our results, combined with those of Khatib et a1,38 indicate that TEF mRNA expression differs in at least one important manner from HLF, as it is consistently expressed in human ALL cell lines, whereas HLF is transcriptionally silent in this lineage. Efforts to detect TEF protein expression in ALL cell lines have been unsuccessful, but it is uncertain whether this was due to true lack of expression or inability of the reagents employed to detect low levels of endogenous TEF."
Our conclusion that the highly conserved THAD is both absolutely necessary and sufficient for transcriptional activation by TEF and HLF substantially refines earlier studies that localized transactivation properties to the amino terminal halves of these protein^.'^,^' Subsequent to completion of the current investigations, Burch et alz reported studies that used GALA chimeric proteins to map the VBP TAD. They found that residues 79-106 (corresponding to human TEF residues 72-99 that comprise the first two thirds of the TAD defined herein) were absolutely required for transcriptional activation to occur. These findings are concordant with our observations. However, in contrast to our findings, full transcriptional activity of GALA-VBP chimeric proteins required VBP residues 79-172, an intermediate construct containing residues 79-137 was approximately fivefold less potent, and residues 79-106 were transcriptionally inactive. There are a number of technical factors that might explain these differences including the use of different reporter constructs and different cell types. It is also possible that the TADs of these homologues differ from one another in some respects, as the amino acid identity between human TEF and residues 11 8-167 of chicken VBP is only 57% (see Fig 2B) .
It is also important to consider what role the THAD might play in transcriptional activation by DBP, which contains a similarly located region that shares significant homology with both TEF and HLF (see Fig 5B) . DBP differs from the other two PAR proteins by virtue of the fact that it activates transcription only in cells of hepatic origin and not in other cell type^.'^,^^ In support of this, we have found that rat DBP does not transactivate the (HLF/TEF),-TK-CAT or (HLF/ TEF),-AP-CAT reporters in CV-1 or REH cells (SPH and MLC, unpublished observations, May 1994). In future studies it will be important to determine if the region of DBP homologous to the THAD functions as a TAD. If so, these proteins would provide ideal reagents with which to study the mechanisms by which cell type specificity is conferred on a TAD.
The primary amino acid sequence of the THAD is unique to the PAR subfamily of bZIP proteins, and analysis of its amino acid composition and predicted secondary structure do not yield any obvious insight into its mode of function. A number of TADs of several different classes have now been described. Recent evidence indicates that transcription factors effect their function by interacting, directly or indirectly, with various protein components of the basal transcription apparatus that is essential for transcription of mRNA by RNA polymerase I1 (reviewed in Tijan"). The primary interaction appears to occur between discrete residues of TADs and individual protein components of the basal transcription apparatus including (but not necessarily limited to) the TATA box binding protein (TBP) and certain of its associated factors (TAFs) within the TFIID complex, TFIIB and TFIIH:o*u48 The fact that the THAD also functions as a TAD in yeast suggests that its target has been highly conserved throughout evolution and will facilitate efforts to understand the biochemical mechanisms by which TEF and HLF activate transcription.
These studies lay important groundwork for future investigations aimed at defining the essential functional properties that E2A and HLF contribute to the t(17; 19)-ALL-associated chimera E2A-HLF. Deletion analyses showing that the HLF leucine zipper and both E2A TADs are absolutely required for tramformation of NIH-3T3 cells support the hypothesis that E2A-HLF contributes to leukemogenesis by activating transcription of crucial target genes.18 If this is true, then one should be able to reconstitute an oncogenic transcription For personal use only. on August 30, 2017. by guest www.bloodjournal.org From factor by taking advantage of the modular nature of functional domains. In the context of this model, our observations suggest that HLF and TEF might also be oncogenic if expressed in the correct cellular context. If they are not, there must either be some fundamental (qualitative or quantitative) differences between the E2A TADs and the THAD, or E2A must contribute other crucial nontranscriptional regulatory properties to the leukemia-associated chimera. Indeed, we have reported previously that E2A-HLF appears to be a modestly more potent transactivator than HLF in transient transfection assays.14 The magnitude of these differences is not striking and it is unclear whether or not it is functionally significant. With respect to the latter possibility, it is important to note that E2A proteins possess growth-inhibitory properties and, when over-expressed in fibroblasts, can block cell cycle progression near the GI-S border.49 The fact that growth inhibition is not completely dependent on the integrity of the bHLH domains supports the possibility that E2A proteins might have important nontranscriptional regulatory proper tie^.^^ One major unresolved question concerning oncogenic transcriptional activators is whether the nature of the TAD and the manner in which it interacts with the basal transcription apparatus are important for oncogenic activity. Are transforming properties retained if an oncoprotein's TAD is replaced with a heterologous TAD (of equivalent potency) that interacts with the same target molecule? With one that contacts a different target molecule? Lessnick et a15' have begun to address this question using the Ewings Sarcoma derived EWS/FLI-1 chimera. Similar to HLF and E2A-HLF, both FLI-1 and EWS-FLI-1 can activate transcription of reporter genes, and the chimera is more potent than wild type FLI-1 .50 When over-expressed via retroviral-mediated gene transfer, full-length EWS-FLI1 efficiently transformed NIH 3T3 cells, whereas wild type and truncated FLI-1 did not. Transformation competency was retained when the EWS portion of the chimera was replaced with some, but not other, heterologous TADs suggesting that these domains are not fully interchangeable. To understand how aberrant transcriptional regulation contributes to malignant transformation, it is essential to perform similar studies with other oncogenic transcription factors. Delineation of the THAD is an important prerequisite for performing such investigations with E2A-HLF and HLF. specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev 5:1739 Dev 5: , 1991 
